Retrospective Analysis of the Real-World Use of the Threshold Suspend Feature of Sensor-Augmented Insulin Pumps

Diabetes Technology and Therapeutics

Volumn 17, Issue 5, 2015, Pages 316-319

  Agrawal, Pratik ^a   Zhong, Alex ^a   Welsh, John B ^a   Shah, Rajiv ^a   Kaufman, Francine R ^a  

^a MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

AREA UNDER THE CURVE; ARTICLE; AUTOMATIC THRESHOLD SUSPENDING INSULIN PUMP; AUTOMATION; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; COMPARATIVE STUDY; GLUCOSE SENSOR; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE MEMORY; ANALYSIS; CIRCADIAN RHYTHM; DEVICES; DIABETES MELLITUS; DRUG EFFECTS; EVALUATION STUDY; GLUCOSE BLOOD LEVEL; INSULIN INFUSION; REFERENCE VALUE; RETROSPECTIVE STUDY; TIME FACTOR;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; REFERENCE VALUES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84934294266     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0257     Document Type: Article

References (9)

1. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1137-1141.
2. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025.
3. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Blasig S, Wadien T, Zierow S, Hartmann R, Thomas A: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13:1129-1134.
4. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012;14:205-209.
5. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW: Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240-1247.
6. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232.
7. Bailey TS, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh JB, Lee SW: Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther 2014;16:277-283.
8. Elbarbary NS: Holding the horses of insulin pump infusion: usage and effectiveness of the low glucose suspend feature during fasting in Ramadan among adolescents with type 1 diabetes mellitus to prevent hypoglycemia [abstract]. Pediatr Diabetes 2014;15(Suppl 19):35.
9. Bailey TS, Garg S, Thrasher J, Bode B, Welsh JB, Zhong A, Agrawal P, Lee SW: ASPIRE clinical trial versus Carelink real-world experiences with insulin pump suspension for mitigation of Iatrogenic Hypoglycemia. In: American Association of Clinical Endocrinologists Annual Meeting Syllabus. Jacksonville, FL; American Association of Clinical Endocrinologists, 2014:23.